Cognitive impairment in fibromyalgia: A meta-analysis of case-control studies. Journal of Psychosomatic Medicine

Yu-Lin Wu, Chun Jen Huang, Su Chen Fang, Ling Hsin Ko, Pei-Shan Tsai

研究成果: 雜誌貢獻回顧型文獻同行評審

摘要

Objective: Cognitive dysfunction has been reported in individuals with fibromyalgia. However, findings regarding cognitive function examined using neuropsychological tests have been inconsistent. The aim of the study was to determine domain-specific cognitive impairment in patients with fibromyalgia compared with healthy controls.

Methods: We conducted a meta-analysis that systematically searched six databases (PubMed, Ovid MEDLINE, Embase, CINAHL, PsycINFO, and Web of Science) for articles published before September 2017.

Results: Twenty-three case-control studies with a total of 2096 participants were included in the meta-analysis. Cognitive function was significantly lower (g = 0.87, 95% confidence interval [CI] = 0.60-1.15) in individuals with fibromyalgia than in healthy controls. Large effect sizes were found in learning/memory and attention/psychomotor speed (g = 0.94, p = .013; g = 1.22, p < .001, respectively); medium effect sizes were reported in executive function and working memory (g = 0.72, p < .001; g = 0.75, p < .001, respectively). Depression and anxiety scores were associated with the effect size of group differences in cognitive function (B = 0.11, p < .001, 95% CI = 0.09-0.13; B = 0.02, p < .001, 95% CI = 0.01-0.02, respectively).

Conclusions: Cognitive impairment across different cognitive domains was found in individuals with fibromyalgia compared with healthy controls. Mood states (depression and anxiety) may explain the heterogeneity across studies.
原文英語
頁(從 - 到)432-438
頁數7
期刊Journal of Psychosomatic Medicine
DOIs
出版狀態已發佈 - 2018

指紋

深入研究「Cognitive impairment in fibromyalgia: A meta-analysis of case-control studies. Journal of Psychosomatic Medicine」主題。共同形成了獨特的指紋。

引用此